Drug therapy - Treatment of acute lymphoblastic leukemia

被引：1423

作者：

Pui, CH

Evans, WE

机构：

[1] St Jude Childrens Res Hosp, Dept Hematol & Oncol, Memphis, TN 38105 USA

[2] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA

[3] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA

[4] Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA

[5] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 02期

关键词：

D O I：

10.1056/NEJMra052603

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：166 / 178

页数：13

共 111 条

[71] Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia [J].

Pession, A ;

Valsecchi, MG ;

Masera, G ;

Kamps, WA ;

Magyarosy, E ;

Rizzari, C ;

van Wering, ER ;

Lo Nigro, L ;

van der Does, A ;

Locatelli, F ;

Basso, G ;

Aricò, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :7161-7167

[72] The best way to use asparaginase in childhood acute lymphatic leukaemia - still to be defined? [J].

Pinheiro, JPV ;

Boos, J .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) :117-127

[73] Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells [J].

Ptasznik, A ;

Nakata, Y ;

Kalota, A ;

Emerson, SG ;

Gewirtz, AM .

NATURE MEDICINE, 2004, 10 (11) :1187-1189

[74] Mechanisms of disease: Acute lymphoblastic leukemia [J].

Pui, C ;

Relling, MV ;

Downing, JR .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1535-1548

[75]

Pui C.-H., 2004, Annals of Hematology, V83, pS124

[76] Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region [J].

Pui, CH ;

Gaynon, PS ;

Boyett, JM ;

Chessells, JM ;

Baruchel, A ;

Kamps, W ;

Silverman, LB ;

Biondi, A ;

Harms, DO ;

Vilmer, E ;

Schrappe, M ;

Camitta, B .

LANCET, 2002, 359 (9321) :1909-1915

[77] Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements [J].

Pui, CH ;

Chessells, JM ;

Camitta, B ;

Baruchel, A ;

Biondi, A ;

Boyett, JM ;

Carroll, A ;

Eden, OB ;

Evans, WE ;

Gadner, H ;

Harbott, J ;

Harms, DO ;

Harrison, CJ ;

Harrison, PL ;

Heerema, N ;

Janka-Schaub, G ;

Kamps, W ;

Masera, G ;

Pullen, J ;

Raimondi, SC ;

Richards, S ;

Riehm, H ;

Sallan, S ;

Sather, H ;

Shuster, J ;

Silverman, LB ;

Valsecchi, MG ;

Vilmer, E ;

Zhou, Y ;

Gaynon, PS ;

Schrappe, M .

LEUKEMIA, 2003, 17 (04) :700-706

[78] Clofarabine [J].

Pui, CH ;

Jeha, S ;

Kirkpatrick, P .

NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (05) :369-370

[79]

Pui CH, 2003, NEW ENGL J MED, V349, P1299

[80] Childhood acute lymphoblastic leukaemia - current status and future perspectives [J].

Pui, CH ;

Campana, D ;

Evans, WE .

LANCET ONCOLOGY, 2001, 2 (10) :597-607

← 3 4 5 6 7 8 9 10 11 12 →